Sponsor:
GlaxoSmithKline
Code:
NCT06534892
Conditions
Respiratory Syncytial Virus Infections
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Accepted
Interventions
RSVPreF3 OA vaccine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2025-08-07.